title: Authors' reply to Elshimy.
authors.affiliation: Division of Applied Medicine, Aberdeen University, Aberdeen, UK a.d.ormerod@abdn.ac.uk.
authors.forename: Anthony D
authors.initials: AD
authors.lastname: Ormerod
authors.affiliation: Centre of Evidence Based Dermatology, University of Nottingham, Nottingham, UK.
authors.forename: Kim S
authors.initials: KS
authors.lastname: Thomas
mesh_terms: D016572:Cyclosporine / Q000008:administration & dosage*; D003879:Dermatologic Agents / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D011239:Prednisolone / Q000008:administration & dosage*; D017511:Pyoderma Gangrenosum / Q000188:drug therapy*; D014647:Varicose Ulcer / Q000188:drug therapy*; D014945:Wound Healing / Q000187:drug effects*
chemical_list: D003879:Dermatologic Agents; D016572:Cyclosporine; D011239:Prednisolone